Seeking Alpha

Hospira (HSP) receives a warning letter from the FDA related to an inspection of the...

Hospira (HSP) receives a warning letter from the FDA related to an inspection of the Company’s La Aurora de Heredia, Costa Rica device manufacturing facility from April 16, 2012 through April 19, 2012. The Costa Rica site manufactures most of the Company’s infusion devices and sets. The Company is still in the process of evaluating what corrective actions are required to address the matters raised in the letter.
Comments (1)
  • rambler1
    , contributor
    Comments (398) | Send Message
     
    Can't these guys do anything right concerning quality control?
    28 Aug 2012, 11:38 PM Reply Like
DJIA (DIA) S&P 500 (SPY)
ETF Tools
Find the right ETFs for your portfolio:
Seeking Alpha's new ETF Hub
ETF Investment Guide:
Table of Contents | One Page Summary
Read about different ETF Asset Classes:
ETF Selector

Next headline on your portfolio:

|